M2 polarized macrophages in bronchoalveolar lavage of lung transplant recipients Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002
Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008
Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 201s Year: 2003
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013
Non-compartmentalisation of inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients Source: Eur Respir J 2005; 26: Suppl. 49, 176s Year: 2005
Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009
Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006
Sputum rather than bronchoalveolar lavage (BAL) cells are associated with small airways function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 198s Year: 2002
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016
Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer. Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016
Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016
Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006
BAL neutrophilia increases mortality in lung transplant patients despite azithromycin treatment Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013
Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002